Wednesday, April 24, 2024
Quick Notes: April 24, 2024
Positive data for MGD treatment; new research could unlock immunotherapy for rare eye cancer; and more.
Wednesday, April 24, 2024
Positive data for MGD treatment; new research could unlock immunotherapy for rare eye cancer; and more.
Wednesday, April 17, 2024
Regeneron issues response to DOJ filing related to Eylea; iHealthScreen awarded patent on AI glaucoma detection model; and more.
Wednesday, April 10, 2024
Positive Phase 3 data for presbyopia treatment; RxSight launches its newest Light Adjustable Lens, the LAL+; and more.
Monday, April 8, 2024
Experts discuss recent advances in glaucoma diagnostics.
By Jim Gallagher, managing editor
Monday, April 8, 2024
The VisuMax 800 femtosecond laser, recently approved by the FDA, demonstrates power and efficiency.
By Jim Gallagher, managing editor
Monday, April 8, 2024
OOSS celebrates a year of successes, welcomes new board leadership at Perspective 2024 luncheon.
By Jim Gallagher, managing editor
Monday, April 8, 2024
Anterior segment surgeons provide pearls for crisis management.
By Jim Gallagher, managing editor
Monday, April 8, 2024
ASCRS and ASOA leaders encourage clinics and surgery centers to reduce waste and embrace sustainable practices.
By Jim Gallagher, managing editor
Sunday, April 7, 2024
Experts discussed the various options to treat aging eyes.
By Jim Gallagher, managing editor
Sunday, April 7, 2024
Proponents of ophthalmic office-based surgery believe that it provides an ideal way to address the growing need for cataract surgery.
Sunday, April 7, 2024
Useful tips and techniques for anterior segment surgeons was the focus of ASCRS lecture.
By Jim Gallagher, managing editor
Sunday, April 7, 2024
Experts provide tips and strategies to help ophthalmic practices thrive despite declining reimbursement.
By Jim Gallagher, managing editor
Sunday, April 7, 2024
Although the initial response has been tepid, presbyopia-correcting drops can still be an excellent choice for certain patients.
By Jim Gallagher, managing editor
Saturday, April 6, 2024
Sessions focused on the latest innovations and techniques in corneal care, as experts presented case studies and surgical videos.
By Jim Gallagher, managing editor
Saturday, April 6, 2024
Experts discuss what's in store for physician reimbursement in 2024 at ASOA session.
By Jim Gallagher, managing editor
Saturday, April 6, 2024
New ASCRS president takes office, and deserving surgeons are honored for their accomplishments
By Jim Gallagher, managing editor
Saturday, April 6, 2024
Surgeons discuss the benefits of refractive lens exchange in Steinert Lecture
By Jim Gallagher, managing editor
Saturday, April 6, 2024
Experts use real-world case studies to discuss surgical techniques and clnical advances in glaucoma treatment.
By Jim Gallagher, managing editor
Wednesday, April 3, 2024
J&J debuts Tecnis Odyssey IOL; Viatris launches RYZUMVl for mydriasis; and more.
Wednesday, March 27, 2024
CMS assigns J-code for GA treatment; glaucoma Mont Blanc Phase 3 trial results; and more.
Wednesday, March 20, 2024
Congress passes partial fix to Medicare physician payment; NovaBay, Eyenovia to co-promote prescription ophthalmic products; and more.
Wednesday, March 13, 2024
Regeneron reports positive data for treatment of wet AMD, DME; drug-eluting contact lens study shows sustained IOP reduction; and more.
Wednesday, March 6, 2024
Glaukos’ iDose TR commercially available in the US; CorNeat EverPatch synthetic tissue launched in US; and more.
Wednesday, February 28, 2024
Four eye ointments voluntarily recalled; CoFi announces market-wide availability of financing solution with CareCredit; and more.
Wednesday, February 21, 2024
New AI products designed to improve efficiency; FDA grants Breakthrough Device Designation for spectacle lenses; and more.
Wednesday, February 14, 2024
Meridian receives FDA approval for the MR Q family of lasers; Study shows Vyzulta’s safety, effectiveness at reducing IOP; and more.
Wednesday, February 7, 2024
FDA warns of contaminated copycat eyedrops; Genentech reports positive long-term data for Vabysmo; and more.
Wednesday, January 31, 2024
AAO warns against eye color-changing surgeries; new company Eyconis formed to develop Ascendis Pharma ophthalmology assets; and more.
Wednesday, January 24, 2024
MIGS device market growth rate of more than 5% expected; Outlook receives FDA agreement for trial; and more.
Wednesday, January 17, 2024
FDA clears Zeiss femtosecond laser for nearsightedness; NIDEK introduces scanning laser ophthalmoscope; and more.
Wednesday, January 10, 2024
FDA approves Bausch + Lomb’s TENEO LASIK platform for myopia and myopic astigmatism; Alcon reports positive data for DED treatment; and more.
Wednesday, January 3, 2024
Five Medicare Administrative Contractors retired their local coverage determinations for MIGS that were scheduled to take effect on Jan. 29, 2024; Harrow partners with three health-care technology platforms to expand US availability of VEVYE; and more.